Glucagon
Brand name: Gvoke Hypopen 2-Pack
Rank #457 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$16.6M
Total Cost
31,523
Total Claims
$16.6M
Total Cost
1,533
Prescribers
$526
Cost per Claim
13,717
Beneficiaries
33,591
30-Day Fills
$11K
Avg Cost/Provider
21
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$16.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $16.6M total
Top Prescribers of Glucagon
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Krishdeep Khosla | Internal Medicine | Oakbrook Terrace, IL | 186 | $124K |
| 2 | Ilona Kharazi | Nurse Practitioner | Elkins Park, PA | 151 | $112K |
| 3 | Aurea Cordero | Nurse Practitioner | Whitehall, PA | 155 | $101K |
| 4 | Jack Noble | Family Practice | Bastrop, LA | 52 | $85K |
| 5 | Anju Gurung | Internal Medicine | Fayetteville, NC | 108 | $78K |
| 6 | Gabriel Uwaifo | Endocrinology | Springfield, IL | 17 | $67K |
| 7 | Dane Ditto | Internal Medicine | Wamego, KS | 22 | $67K |
| 8 | Anju Gurung | Internal Medicine | Fayetteville, NC | 102 | $65K |
| 9 | Kylee Wilkinson | Nurse Practitioner | Rocky Mount, NC | 89 | $60K |
| 10 | Fan Zhang | Endocrinology | Brooklyn, NY | 90 | $60K |
| 11 | Chih Chang | Endocrinology | Sellersburg, IN | 80 | $58K |
| 12 | Grace Spencer | Nurse Practitioner | Birmingham, AL | 89 | $58K |
| 13 | Leslie Rumbaut | Physician Assistant | Grenville, SC | 79 | $58K |
| 14 | Troy Ellis | Physician Assistant | Jacksonville, FL | 85 | $55K |
| 15 | Nilay Desai | Endocrinology | Rocky Mount, NC | 90 | $55K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 454 | Nitroglycerin (Nitroglycerin) | $16.8M | 768,384 |
| 455 | Lanreotide Acetate (Somatuline Depot) | $16.7M | 1,753 |
| 456 | Clonidine (Clonidine) | $16.7M | 112,710 |
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology